Ensysce Biosciences, Inc. (ENSC) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on July 1, 2021, by Ensysce Biosciences, Inc., a Delaware corporation formerly known as Leisure Acquisition Corp. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The Company is an emerging growth company.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses on corporate governance and trading status rather than financial performance.
Material Changes
- Trading Commencement: On July 1, 2021, the Company's Common Stock (Trading Symbol: ENSC) began trading on The Nasdaq Stock Market LLC.
- Warrant Trading: Warrants to purchase one share of Common Stock (Trading Symbol: ENSCW) began trading on the OTC Markets Group, Inc.
- Corporate Identity: The filing confirms the transition from the former name, Leisure Acquisition Corp., to Ensysce Biosciences, Inc.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the Company's future performance, which are subject to risks and uncertainties, including changes in general economic conditions and the impact of COVID-19. Management cautions that actual results may differ materially from expectations. No specific financial guidance or operational outlook is provided in this document.
Investor Verification Checklist
- Verify the commencement of trading for Common Stock (ENSC) on Nasdaq and Warrants (ENSCW) on OTC Markets.
- Review the attached Press Release (Exhibit 99.1) for details on the business combination or merger that led to the name change and trading status.
- Consult the Company's previous filings under the name "Leisure Acquisition Corp." for historical financial data and risk factors.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.